Clinical Trial

Aclaris Therapeutics to Host In-Person and Webcast R&D Day, “Patient Focused Innovation: Addressing Gaps in Immuno-Inflammatory Markets”, in New York on October 14, 2025

WAYNE, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing...

Children’s Hospital of Philadelphia Pediatric Cancer Researcher Receives Prestigious Grant for Advancing Rare Tumor Studies

 Grant supports CHOP's dedication to understanding and treating rare tumors  PHILADELPHIA, Sept. 29, 2025 /PRNewswire/ -- Children's Hospital of Philadelphia...

Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject

The FDA agrees that the Company may follow 505(b)(2) regulatory pathway to non-invasively treat basal cell carcinoma (BCC) of the...

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Data show results consistent with clinical trial experienceA high level of safety – no device-related adverse eventsStrong survival data extending...

Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology

VANCOUVER, BC / ACCESS Newswire / September 29, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased...

President Trump Clears the Path for Medical Marijuana Reform – But Why Is DEA Attorney Aarathi Haig Still Practicing Law with Ethical Violations

"DEA has already admitted its tribunal system was unconstitutional. Yet dirty cops and unethical attorneys like Aarathi Haig are still...

Smart Sleep Tracker Market is expected to generate a revenue of USD 68.31 Billion by 2032, Globally, at 12.4% CAGR: Verified Market Research®

The Smart Sleep Tracker Market is experiencing rapid growth, driven by rising health awareness, increasing adoption of wearable devices, and...

Deep EigenMatics Receives United States Patent for Inventing Breakthrough Artificial Intelligence Method for Protein Design and Drug Discovery

SUGAR LAND, Texas, Sept. 26, 2025 /PRNewswire/ -- Deep EigenMatics, a startup developing innovative Artificial Intelligence methods for drug discovery and...

UPDATE — ADvantage Therapeutics Awarded $2.5 Million NIH SBIR Grant to Advance Alzheimer’s Drug Candidate AD04® Toward the Clinic

MIAMI, Sept. 26, 2025 (GLOBE NEWSWIRE) -- ADvantage Therapeutics, Inc., a biotechnology company developing novel therapies for neurodegenerative diseases, today...

error: Content is protected !!